$FRMM
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Healthcare
Sector
Biotechnology
Industry
Lloyd Blair Jordan
CEO
4
Employees
$5.58
Current Price
$1.08B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $1,500,000.00 | 250,000 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 5 | $1,567,464.06 | 260,751 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 5 | $1,567,464.06 | 260,751 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 5 | $1,567,464.06 | 260,751 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Lomashuk Konstantin 10% Owner | Sale | 250,000 | $6.00 | $1,500,000.00 | View Details |
| Jul 15, 2026 | Lomashuk Konstantin 10% Owner | Sale | 2,562 | $6.30 | $16,140.86 | View Details |
| Jul 9, 2026 | Lomashuk Konstantin 10% Owner | Sale | 3,387 | $6.15 | $20,846.31 | View Details |
| Jul 7, 2026 | Lomashuk Konstantin 10% Owner | Sale | 3,702 | $6.41 | $23,733.89 | View Details |
| Jul 8, 2026 | Lomashuk Konstantin 10% Owner | Sale | 1,100 | $6.13 | $6,743.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.